Running on Empty: New Paper Explains Why Vaccine-Injured Patients Stay Exhausted
Why do long COVID and PACVS patients crash after simple activities? A new review by IMA researchers pinpoints three broken energy pathways and what to do about them.
IMA President Dr. Joseph Varon Speaks with Full Measure on Pharma Bias in Medical Journals
Dr. Joseph Varon tells Full Measure why he launched the Journal of Independent Medicine to counter Big Pharma's grip on medical publishing.
Status Quo Fights Back: Congressional Partisans Petition HHS in Attempt to Block ACIP’s Review & Discussion of ‘the Science’
IMA responds to Democratic lawmakers' petition to remove two OB-GYNs from the CDC's vaccine advisory committee, defending open scientific debate and rigorous review of vaccine data in pregnancy.
From Roots to Remedies: Exploring Herbal and Integrative Medicine in Patient Care
Dr. Cole, Dr. Carman, and Dr. Varon explore how Traditional Chinese Medicine, herbal protocols, and acupuncture are being applied to complex chronic illness today.
How Long Do COVID-19 Vaccine Components Really Last in the Body? A New Study Has Answers
A new systematic review of 20 studies documents COVID-19 vaccine mRNA, spike protein, and lipid nanoparticles persisting in blood and tissues for months to years. The authors call for urgent investigation.
Why the Medical Freedom Act Coalition Matters Now: How States Are Leading the Fight
The Medical Freedom Act Coalition is pushing legislation in multiple states to end medical mandates. Leslie Manookian and Leah Wilson break down the Idaho model, where bills stand in 2026, and how citizens can take action.
Independent Medical Alliance Responds to Texas AG Paxton’s Support of Dr. Mary Talley Bowden
“Why is the Texas Medical Board still fighting a war they’ve already lost? And why are they punishing Dr. Bowden for doing exactly what good doctors are supposed to do, fighting for her patients.” — Dr. Joseph Varon
World-Renowned Physicians and Scientific Leaders Convene in Texas this April for IMA’s 5th Annual Medical Education Conference
Two-day CME-accredited event spotlights innovation, ethics, and Emerging Trends in Medicine: Early Bird pricing ends February 28.
Major New Study: “Measles Is Highly Treatable” IMA Peer-Reviewed Study Published in Antiviral Research
Comprehensive analysis highlights evidence-based therapeutic strategies and calls for a broader public health conversation around Measles.
New Study Reviews Therapeutic Candidates for Measles
A new peer-reviewed study from IMA researchers reviews therapeutic candidates for measles, including Vitamin A. Why isn't this part of the conversation?
